{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:36:29Z","timestamp":1794263789015,"version":"4.9.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["FRQS; Chercheur Boursier and 2020-VICO-279314"],"award-info":[{"award-number":["FRQS; Chercheur Boursier and 2020-VICO-279314"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-11-51-31, FRN, 152985"],"award-info":[{"award-number":["MOP-11-51-31, FRN, 152985"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u201c\u2019s Association","doi-asserted-by":"publisher","award":["NIRG-12- 92090, NIRP-12-259245"],"award-info":[{"award-number":["NIRG-12- 92090, NIRP-12-259245"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41386-022-01293-6","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T09:03:00Z","timestamp":1645088580000},"page":"1128-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"47","author":[{"given":"Clifford M.","family":"Cassidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Savard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8726-0467","authenticated-orcid":false,"given":"Lauri","family":"Tuominen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Chamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyda","family":"Celebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoza","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gassan","family":"Massarweh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-3731","authenticated-orcid":false,"given":"Zahinoor","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-1376","authenticated-orcid":false,"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"1293_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jalz.2016.06.2362","volume":"13","author":"P Theofilas","year":"2017","unstructured":"Theofilas P, Ehrenberg AJ, Dunlop S, Di Lorenzo Alho AT, Nguy A, Leite REP, et al. Locus coeruleus volume and cell population changes during Alzheimer\u2019s disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery. Alzheimers Dement. 2017;13:236\u201346.","journal-title":"Alzheimers Dement"},{"key":"1293_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tins.2018.01.010","volume":"41","author":"D Weinshenker","year":"2018","unstructured":"Weinshenker D. Long road to ruin: noradrenergic dysfunction in neurodegenerative disease. Trends Neurosci. 2018;41:211\u201323.","journal-title":"Trends Neurosci"},{"key":"1293_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnins.2015.00220","volume":"9","author":"M Gannon","year":"2015","unstructured":"Gannon M, Che P, Chen Y, Jiao K, Roberson ED, Wang Q. Noradrenergic dysfunction in Alzheimer\u2019s disease. Front Neurosci. 2015;9:220.","journal-title":"Front Neurosci"},{"key":"1293_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.brainres.2017.12.027","volume":"1702","author":"A Satoh","year":"2019","unstructured":"Satoh A, Iijima KM. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer\u2019s disease pathogenesis: Potential strategies to protect the LC against aging. Brain Res. 2019;1702:17\u201328.","journal-title":"Brain Res"},{"key":"1293_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","volume":"4","author":"D Sulzer","year":"2018","unstructured":"Sulzer D, Cassidy C, Horga G, Kang UJ, Fahn S, Casella L, et al. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease. NPJ Parkinsons Dis. 2018;4:11.","journal-title":"NPJ Parkinsons Dis"},{"key":"1293_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroimage.2015.03.020","volume":"113","author":"NI Keren","year":"2015","unstructured":"Keren NI, Taheri S, Vazey EM, Morgan PS, Granholm AC, Aston-Jones GS, et al. Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. Neuroimage. 2015;113:235\u201345.","journal-title":"Neuroimage."},{"key":"1293_CR7","doi-asserted-by":"publisher","first-page":"583421","DOI":"10.3389\/fnins.2020.583421","volume":"14","author":"M Kelberman","year":"2020","unstructured":"Kelberman M, Keilholz S, Weinshenker D. What\u2019s that (blue) spot on my MRI? Multimodal neuroimaging of the locus coeruleus in neurodegenerative disease. Front Neurosci. 2020;14:583421.","journal-title":"Front Neurosci"},{"key":"1293_CR8","doi-asserted-by":"publisher","first-page":"eabj2511","DOI":"10.1126\/scitranslmed.abj2511","volume":"13","author":"HIL Jacobs","year":"2021","unstructured":"Jacobs HIL, Becker JA, Kwong K, Engels-Dominguez N, Prokopiou PC, Papp KV, et al. In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer\u2019s disease pathology and cognitive decline. Sci Transl Med. 2021;13:eabj2511.","journal-title":"Sci Transl Med"},{"key":"1293_CR9","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00429-019-01858-0","volume":"224","author":"T Watanabe","year":"2019","unstructured":"Watanabe T, Tan Z, Wang X, Martinez-Hernandez A, Frahm J. Magnetic resonance imaging of noradrenergic neurons. Brain Struct Funct. 2019;224:1609\u201325.","journal-title":"Brain Struct Funct"},{"key":"1293_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/brain\/awx348","volume":"141","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer M, Fedorova TD, Hansen AK, Knudsen K, Otto M, Jeppesen J, et al. Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study. Brain. 2018;141:496\u2013504.","journal-title":"Brain."},{"key":"1293_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/acn3.50818","volume":"6","author":"P Olivieri","year":"2019","unstructured":"Olivieri P, Lagarde J, Lehericy S, Valabregue R, Michel A, Mace P, et al. Early alteration of the locus coeruleus in phenotypic variants of Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2019;6:1345\u201351.","journal-title":"Ann Clin Transl Neurol"},{"key":"1293_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/ADR-170021","volume":"1","author":"M Dordevic","year":"2017","unstructured":"Dordevic M, Muller-Fotti A, Muller P, Schmicker M, Kaufmann J, Muller NG. Optimal cut-off value for locus coeruleus-to-pons intensity ratio as clinical biomarker for Alzheimer\u2019s disease: a pilot study. J Alzheimers Dis Rep. 2017;1:159\u201367.","journal-title":"J Alzheimers Dis Rep"},{"key":"1293_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/ggi.12280","volume":"15","author":"J Takahashi","year":"2015","unstructured":"Takahashi J, Shibata T, Sasaki M, Kudo M, Yanezawa H, Obara S, et al. Detection of changes in the locus coeruleus in patients with mild cognitive impairment and Alzheimer\u2019s disease: high-resolution fast spin-echo T1-weighted imaging. Geriatr Gerontol Int. 2015;15:334\u201340.","journal-title":"Geriatr Gerontol Int"},{"key":"1293_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.euroneuro.2020.12.013","volume":"43","author":"R Hou","year":"2021","unstructured":"Hou R, Beardmore R, Holmes C, Osmond C, Darekar A. A case-control study of the locus coeruleus degeneration in Alzheimer\u2019s disease. Eur Neuropsychopharmacol. 2021;43:153\u201359.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1293_CR15","first-page":"281","volume":"11","author":"MJ Betts","year":"2019","unstructured":"Betts MJ, Cardenas-Blanco A, Kanowski M, Spottke A, Teipel SJ, Kilimann I, et al. Locus coeruleus MRI contrast is reduced in Alzheimer\u2019s disease dementia and correlates with CSF Abeta levels. Alzheimers Dement. 2019;11:281\u201385.","journal-title":"Alzheimers Dement"},{"key":"1293_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","volume":"7","author":"C Aguero","year":"2019","unstructured":"Aguero C, Dhaynaut M, Normandin MD, Amaral AC, Guehl NJ, Neelamegam R. et al. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019;7:37.","journal-title":"Acta Neuropathol Commun"},{"key":"1293_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.2967\/jnumed.112.114785","volume":"54","author":"CC Rowe","year":"2013","unstructured":"Rowe CC, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, et al. Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for \u03b2-amyloid imaging in aging and dementia. J Nucl Med. 2013;54:880\u20136.","journal-title":"J Nucl Med"},{"key":"1293_CR18","doi-asserted-by":"crossref","unstructured":"Therriault J, Benedet A, Pascoal TA, Savard M, Ashton N, Chamoun M, et al. Determining amyloid-beta positivity using [(18)F]AZD4694 PET imaging. J Nucl Med. 2020;62:247\u201352.","DOI":"10.2967\/jnumed.120.245209"},{"key":"1293_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/alz.12007","volume":"16","author":"FZ Lussier","year":"2020","unstructured":"Lussier FZ, Pascoal TA, Chamoun M, Therriault J, Tissot C, Savard M, et al. Mild behavioral impairment is associated with \u03b2-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Alzheimers Dement. 2020;16:192\u201399.","journal-title":"Alzheimers Dement"},{"key":"1293_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-7091-7508-8_8","volume":"54","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA, Bancher C. Neuropathology of Alzheimer\u2019s disease: a critical update. J Neural Transm Suppl. 1998;54:77\u201395.","journal-title":"J Neural Transm Suppl"},{"key":"1293_CR21","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1212\/WNL.0000000000011081","volume":"96","author":"J Therriault","year":"2021","unstructured":"Therriault J, Pascoal TA, Benedet AL, Tissot C, Savard M, Chamoun M, et al. Frequency of biologically defined Alzheimer disease in relation to age, sex, APOE epsilon4, and cognitive impairment. Neurology. 2021;96:e975\u201385.","journal-title":"Neurology."},{"key":"1293_CR22","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1093\/brain\/awaa180","volume":"143","author":"TA Pascoal","year":"2020","unstructured":"Pascoal TA, Therriault J, Benedet AL, Savard M, Lussier FZ, Chamoun M, et al. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain. 2020;143:2818\u201330.","journal-title":"Brain."},{"key":"1293_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainres.2017.12.028","volume":"1702","author":"D Braun","year":"2019","unstructured":"Braun D, Feinstein DL. The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer\u2019s disease. Brain Res. 2019;1702:29\u201337.","journal-title":"Brain Res"},{"key":"1293_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/jnp.16.3.261","volume":"16","author":"N Herrmann","year":"2004","unstructured":"Herrmann N, Lanctot KL, Khan LR. The role of norepinephrine in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci. 2004;16:261\u201376.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1293_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.trci.2017.07.001","volume":"3","author":"KL Lanctot","year":"2017","unstructured":"Lanctot KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, et al. Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: new treatment paradigms. Alzheimers Dement. 2017;3:440\u201349.","journal-title":"Alzheimers Dement"},{"key":"1293_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00002093-200401000-00004","volume":"18","author":"TJ Hwang","year":"2004","unstructured":"Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord. 2004;18:17\u201321.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1293_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-170001","volume":"59","author":"JR Gatchel","year":"2017","unstructured":"Gatchel JR, Donovan NJ, Locascio JJ, Schultz AP, Becker JA, Chhatwal J, et al. Depressive symptoms and tau accumulation in the inferior temporal lobe and entorhinal cortex in cognitively normal older adults: a pilot study. J Alzheimers Dis. 2017;59:975\u201385.","journal-title":"J Alzheimers Dis"},{"key":"1293_CR28","first-page":"333","volume":"11","author":"EA Wise","year":"2019","unstructured":"Wise EA, Rosenberg PB, Lyketsos CG, Leoutsakos JM. Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer\u2019s Coordinating Centers volunteers. Alzheimers Dement. 2019;11:333\u201339.","journal-title":"Alzheimers Dement"},{"key":"1293_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","volume":"7","author":"CG Lyketsos","year":"2011","unstructured":"Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. Neuropsychiatric symptoms in Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:532\u20139.","journal-title":"Alzheimers Dement"},{"key":"1293_CR30","first-page":"105","volume":"2","author":"RF Allegri","year":"2006","unstructured":"Allegri RF, Sarasola D, Serrano CM, Taragano FE, Arizaga RL, Butman J, et al. Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer\u2019s disease. Neuropsychiatr Dis Treat. 2006;2:105\u201310.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1293_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/01.JGP.0000308883.64832.ed","volume":"16","author":"JC Nelson","year":"2008","unstructured":"Nelson JC, Delucchi K, Schneider LS. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry. 2008;16:558\u201367.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1293_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","volume":"14","author":"LS Schneider","year":"2006","unstructured":"Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006;14:191\u2013210.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1293_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/JGP.0b013e3181cc0333","volume":"18","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, et al. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry. 2010;18:332\u201340.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1293_CR34","doi-asserted-by":"crossref","unstructured":"Jacobs HIL, Riphagen JM, Ramakers IHGB, Verhey FRJ. Alzheimer\u2019s disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms. Mol Psychiatry. 2019;26:897\u2013906.","DOI":"10.1038\/s41380-019-0437-x"},{"key":"1293_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-140309","volume":"41","author":"Y Vermeiren","year":"2014","unstructured":"Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer\u2019s disease. J Alzheimers Dis. 2014;41:819\u201333.","journal-title":"J Alzheimers Dis"},{"key":"1293_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.arr.2018.03.003","volume":"43","author":"KY Liu","year":"2018","unstructured":"Liu KY, Stringer AE, Reeves SJ, Howard RJ. The neurochemistry of agitation in Alzheimer\u2019s disease: a systematic review. Ageing Res Rev. 2018;43:99\u2013107.","journal-title":"Ageing Res Rev"},{"key":"1293_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.JGP.0000237065.78966.1b","volume":"15","author":"SI Sharp","year":"2007","unstructured":"Sharp SI, Ballard CG, Chen CP, Francis PT. Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease. Am J Geriatr Psychiatry. 2007;15:435\u20137.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1293_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/0269881104042625","volume":"18","author":"N Herrmann","year":"2004","unstructured":"Herrmann N, Lanctot KL, Eryavec G, Khan LR. Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer\u2019s disease patients. J Psychopharmacol. 2004;18:215\u201320.","journal-title":"J Psychopharmacol"},{"key":"1293_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.wad.0000155067.16313.5e","volume":"19","author":"ER Peskind","year":"2005","unstructured":"Peskind ER, Tsuang DW, Bonner LT, Pascualy M, Riekse RG, Snowden MB, et al. Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study. Alzheimer Dis Assoc Disord. 2005;19:23\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1293_CR40","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/JGP.0b013e3181ab8c61","volume":"17","author":"LY Wang","year":"2009","unstructured":"Wang LY, Shofer JB, Rohde K, Hart KL, Hoff DJ, McFall YH, et al. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Geriatr Psychiatry. 2009;17:744\u201351.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1293_CR41","doi-asserted-by":"publisher","first-page":"P372","DOI":"10.1093\/geronj\/46.6.P372","volume":"46","author":"L Teri","year":"1991","unstructured":"Teri L, Reifler BV, Veith RC, Barnes R, White E, McLean P, et al. Imipramine in the treatment of depressed Alzheimer\u2019s patients: impact on cognition. J Gerontol. 1991;46:P372\u20137.","journal-title":"J Gerontol"},{"key":"1293_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0169-328X(00)00168-6","volume":"84","author":"P Szot","year":"2000","unstructured":"Szot P, Leverenz JB, Peskind ER, Kiyasu E, Rohde K, Miller MA, et al. Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimer\u2019s disease. Brain Res Mol Brain Res. 2000;84:135\u201340.","journal-title":"Brain Res Mol Brain Res"},{"key":"1293_CR43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1523\/JNEUROSCI.4265-05.2006","volume":"26","author":"P Szot","year":"2006","unstructured":"Szot P, White SS, Greenup JL, Leverenz JB, Peskind ER, Raskind MA. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer\u2019s disease and dementia with Lewy bodies. J Neurosci. 2006;26:467\u201378.","journal-title":"J Neurosci"},{"key":"1293_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1176\/ajp.154.1.25","volume":"154","author":"R Elrod","year":"1997","unstructured":"Elrod R, Peskind ER, DiGiacomo L, Brodkin KI, Veith RC, Raskind MA. Effects of Alzheimer\u2019s disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiatry. 1997;154:25\u201330.","journal-title":"Am J Psychiatry"},{"key":"1293_CR45","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/archneur.1991.00530180075020","volume":"48","author":"GS Zubenko","year":"1991","unstructured":"Zubenko GS, Moossy J, Martinez AJ, Rao G, Claassen D, Rosen J, et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol. 1991;48:619\u201324.","journal-title":"Arch Neurol"},{"key":"1293_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00234-009-0595-7","volume":"52","author":"M Sasaki","year":"2010","unstructured":"Sasaki M, Shibata E, Ohtsuka K, Endoh J, Kudo K, Narumi S, et al. Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging. Neuroradiology. 2010;52:83\u20139.","journal-title":"Neuroradiology."},{"key":"1293_CR47","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/brain\/awt152","volume":"136","author":"D Garcia-Lorenzo","year":"2013","unstructured":"Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, et al. The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson\u2019s disease. Brain. 2013;136:2120\u20139.","journal-title":"Brain."},{"key":"1293_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neuroimage.2017.02.025","volume":"150","author":"M Mather","year":"2017","unstructured":"Mather M, Joo Yoo H, Clewett DV, Lee TH, Greening SG, Ponzio A, et al. Higher locus coeruleus MRI contrast is associated with lower parasympathetic influence over heart rate variability. Neuroimage. 2017;150:329\u201335.","journal-title":"Neuroimage."},{"key":"1293_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0456-z","volume":"9","author":"J Krell-Roesch","year":"2019","unstructured":"Krell-Roesch J, Vassilaki M, Mielke MM, Kremers WK, Lowe VJ, Vemuri P, et al. Cortical \u03b2-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging. Transl Psychiatry. 2019;9:123.","journal-title":"Transl Psychiatry"},{"key":"1293_CR50","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2174\/1567205013666160502123607","volume":"13","author":"D Van Dam","year":"2016","unstructured":"Van Dam D, Vermeiren Y, Dekker AD, Naude PJ, Deyn PP. Neuropsychiatric disturbances in Alzheimer\u2019s disease: what have we learned from neuropathological studies? Curr Alzheimer Res. 2016;13:1145\u201364.","journal-title":"Curr Alzheimer Res"},{"key":"1293_CR51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JAD-190365","volume":"71","author":"A Showraki","year":"2019","unstructured":"Showraki A, Murari G, Ismail Z, Barfett JJ, Fornazzari L, Munoz DG, et al. Cerebrospinal fluid correlates of neuropsychiatric symptoms in patients with Alzheimer\u2019s disease\/mild cognitive impairment: a systematic review. J Alzheimers Dis. 2019;71:477\u2013501.","journal-title":"J Alzheimers Dis"},{"key":"1293_CR52","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3233\/JAD-160979","volume":"56","author":"Z Ismail","year":"2017","unstructured":"Ismail Z, Aguera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, et al. The mild behavioral impairment checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis. 2017;56:929\u201338.","journal-title":"J Alzheimers Dis"},{"key":"1293_CR53","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3233\/JAD-190113","volume":"70","author":"Y Cui","year":"2019","unstructured":"Cui Y, Dai S, Miao Z, Zhong Y, Liu Y, Liu L, et al. Reliability and validity of the Chinese version of the mild behavioral impairment checklist for screening for Alzheimer\u2019s disease. J Alzheimers Dis. 2019;70:747\u201356.","journal-title":"J Alzheimers Dis"},{"key":"1293_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/JAD-180131","volume":"66","author":"SC Mallo","year":"2018","unstructured":"Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, et al. Assessing mild behavioral impairment with the mild behavioral impairment-checklist in people with mild cognitive impairment. J Alzheimers Dis. 2018;66:83\u201395.","journal-title":"J Alzheimers Dis"},{"key":"1293_CR55","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Chamoun M, Savard M, et al. Association of apolipoprotein E epsilon4 with medial temporal tau independent of amyloid-beta. JAMA Neurol. 2020;77:470\u201379.","journal-title":"JAMA Neurol"},{"key":"1293_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"1293_CR57","doi-asserted-by":"crossref","unstructured":"Jacobs HI, Priovoulos N, Poser BA, Pagen LH, Ivanov D, Verhey FR, et al. Dynamic behavior of the locus coeruleus during arousal-related memory processing in a multi-modal 7T fMRI paradigm. Elife. 2020;9:e52059.","DOI":"10.7554\/eLife.52059"},{"key":"1293_CR58","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.1807983116","volume":"116","author":"CM Cassidy","year":"2019","unstructured":"Cassidy CM, Zucca FA, Girgis RR, Baker SC, Weinstein JJ, Sharp ME, et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci USA. 2019;116:5108\u201317.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1293_CR59","doi-asserted-by":"crossref","unstructured":"Wengler K, Ashinoff BK, Pueraro E, Cassidy CM, Horga G, Rutherford BR. Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression. Neuropsychopharmacology. 2020;46:1233\u201339.","DOI":"10.1038\/s41386-020-00860-z"},{"key":"1293_CR60","doi-asserted-by":"crossref","unstructured":"Naidich TP, Duvernoy HM, Delman BN, Sorensen AG, Kollias SS, Haacke ME. Duvernoy\u2019s atlas of the human brain stem and cerebellum: high-field MRI: surface anatomy, internal structure, vascularization and 3D sectional anatomy. Wien, New York: Springer; 2009.","DOI":"10.1007\/978-3-211-73971-6"},{"key":"1293_CR61","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.410320510","volume":"32","author":"DC German","year":"1992","unstructured":"German DC, Manaye KF, White CL 3rd, Woodward DJ, McIntire DD, Smith WK, et al. Disease-specific patterns of locus coeruleus cell loss. Ann Neurol. 1992;32:667\u201376.","journal-title":"Ann Neurol"},{"key":"1293_CR62","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.mri.2014.07.003","volume":"32","author":"X Chen","year":"2014","unstructured":"Chen X, Huddleston DE, Langley J, Ahn S, Barnum CJ, Factor SA, et al. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Magn Reson Imaging. 2014;32:1301\u20136.","journal-title":"Magn Reson Imaging"},{"key":"1293_CR63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","volume":"10","author":"TA Pascoal","year":"2018","unstructured":"Pascoal TA, Shin M, Kang MS, Chamoun M, Chartrand D, Mathotaarachchi S, et al. In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240. Alzheimers Res Ther. 2018;10:74.","journal-title":"Alzheimers Res Ther"},{"key":"1293_CR64","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2967\/jnumed.111.094029","volume":"53","author":"Z Csel\u00e9nyi","year":"2012","unstructured":"Csel\u00e9nyi Z, J\u00f6nhagen ME, Forsberg A, Halldin C, Julin P, Schou M, et al. Clinical validation of 18F-AZD4694, an amyloid-\u03b2-specific PET radioligand. J Nucl Med. 2012;53:415\u201324.","journal-title":"J Nucl Med"},{"key":"1293_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/nimg.1995.1012","volume":"2","author":"JC Mazziotta","year":"1995","unstructured":"Mazziotta JC, Toga AW, Evans A, Fox P, Lancaster J. A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage. 1995;2:89\u2013101.","journal-title":"Neuroimage."},{"key":"1293_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement. 2017;13:205\u201316.","journal-title":"Alzheimers Dement"},{"key":"1293_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"1293_CR68","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18:351\u20137.","journal-title":"Neurobiol Aging"},{"key":"1293_CR69","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389\u2013404.","journal-title":"Acta Neuropathol"},{"key":"1293_CR70","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70:960\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1293_CR71","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0006-3223(01)01235-5","volume":"51","author":"KL Matthews","year":"2002","unstructured":"Matthews KL, Chen CP, Esiri MM, Keene J, Minger SL, Francis PT. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry. 2002;51:407\u201316.","journal-title":"Biol Psychiatry"},{"key":"1293_CR72","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41583-020-0360-9","volume":"21","author":"GR Poe","year":"2020","unstructured":"Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. Locus coeruleus: a new look at the blue spot. Nat Rev Neurosci. 2020;21:644\u201359.","journal-title":"Nat Rev Neurosci"},{"key":"1293_CR73","doi-asserted-by":"crossref","unstructured":"Hirschberg S, Li Y, Randall A, Kremer EJ, Pickering AE. Functional dichotomy in spinal- vs prefrontal-projecting locus coeruleus modules splits descending noradrenergic analgesia from ascending aversion and anxiety in rats. Elife. 2017;6:e29808.","DOI":"10.7554\/eLife.29808"},{"key":"1293_CR74","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2174\/157015908785777193","volume":"6","author":"ER Samuels","year":"2008","unstructured":"Samuels ER, Szabadi E. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol. 2008;6:254\u201385.","journal-title":"Curr Neuropharmacol"},{"key":"1293_CR75","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0306-4522(77)90009-4","volume":"2","author":"KC Gatter","year":"1977","unstructured":"Gatter KC, Powell TP. The projection of the locus coeruleus upon the neocortex in the macaque monkey. Neuroscience. 1977;2:441\u20135.","journal-title":"Neuroscience."},{"key":"1293_CR76","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s00429-020-02153-z","volume":"225","author":"N Priovoulos","year":"2020","unstructured":"Priovoulos N, van Boxel SCJ, Jacobs HIL, Poser BA, Uludag K, Verhey FRJ, et al. Unraveling the contributions to the neuromelanin-MRI contrast. Brain Struct Funct. 2020;225:2757\u201374.","journal-title":"Brain Struct Funct"},{"key":"1293_CR77","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1185\/030079905X65402","volume":"21","author":"GT Grossberg","year":"2005","unstructured":"Grossberg GT. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer\u2019s disease. Curr Med Res Opin. 2005;21:1631\u20139.","journal-title":"Curr Med Res Opin"},{"key":"1293_CR78","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/alz.12007","volume":"16","author":"FZ Lussier","year":"2020","unstructured":"Lussier FZ, Pascoal TA, Chamoun M, Therriault J, Tissot C, Savard M, et al. Mild behavioral impairment is associated with beta-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Alzheimers Dement. 2020;16:192\u201399.","journal-title":"Alzheimers Dement"},{"key":"1293_CR79","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuropharm.2015.09.003","volume":"101","author":"P Szot","year":"2016","unstructured":"Szot P, Franklin A, Miguelez C, Wang Y, Vidaurrazaga I, Ugedo L, et al. Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine. Neuropharmacology. 2016;101:76\u201386.","journal-title":"Neuropharmacology."},{"key":"1293_CR80","doi-asserted-by":"crossref","unstructured":"Elman JA, Puckett OK, Beck A, Fennema-Notestine C, Cross LK, Dale AM, et al. MRI-assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction. Alzheimers Dement. 2021;17:1017\u201325.","DOI":"10.1002\/alz.12261"},{"key":"1293_CR81","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.neuroimage.2017.07.045","volume":"168","author":"N Priovoulos","year":"2018","unstructured":"Priovoulos N, Jacobs HIL, Ivanov D, Uludag K, Verhey FRJ, Poser BA. High-resolution in vivo imaging of human locus coeruleus by magnetization transfer MRI at 3T and 7T. Neuroimage. 2018;168:427\u201336.","journal-title":"Neuroimage."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01293-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01293-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01293-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T07:13:16Z","timestamp":1666595596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01293-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1293"],"URL":"https:\/\/doi.org\/10.1038\/s41386-022-01293-6","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no competing financial interest in relation to the study design, results, or discussion. CMC and PR-N are inventors on a pending patent using the analysis method described here, licensed to Terran Biosciences, but have received no royalties.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}